Literature DB >> 9431302

The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States.

J Tuttle1, R T Chen, H Rantala, J D Cherry, P H Rhodes, S Hadler.   

Abstract

OBJECTIVES: This study examined whether there is a risk that tetanus-toxoid-containing vaccines could cause Guillain-Barré syndrome and, if so, how large the risk is.
METHODS: This study was based on previous active surveillance epidemiological studies of Guillain-Barré syndrome and vaccination history.
RESULTS: A background rate of 0.3 cases of Guillain-Barré syndrome per million person-weeks has been estimated. By chance, 2.2 people with the syndrome would have received tetanus-toxoid-containing vaccine within the 6 weeks before onset, yet only 1 person had done so. Data on children show similar results.
CONCLUSIONS: If an association exists, it must be extremely rare and not of public health significance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9431302      PMCID: PMC1381255          DOI: 10.2105/ajph.87.12.2045

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  7 in total

1.  Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two-state study. Expert Neurology Group.

Authors:  T J Safranek; D N Lawrence; L T Kurland; D H Culver; W C Wiederholt; N S Hayner; M T Osterholm; P O'Brien; J M Hughes
Journal:  Am J Epidemiol       Date:  1991-05-01       Impact factor: 4.897

2.  Criteria for diagnosis of Guillain-Barré syndrome.

Authors: 
Journal:  Ann Neurol       Date:  1978-06       Impact factor: 10.422

Review 3.  Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease.

Authors:  P M Strebel; R W Sutter; S L Cochi; R J Biellik; E W Brink; O M Kew; M A Pallansch; W A Orenstein; A R Hinman
Journal:  Clin Infect Dis       Date:  1992-02       Impact factor: 9.079

4.  Epidemiology of Guillain-Barré syndrome in children: relationship of oral polio vaccine administration to occurrence.

Authors:  H Rantala; J D Cherry; W D Shields; M Uhari
Journal:  J Pediatr       Date:  1994-02       Impact factor: 4.406

5.  A prospective study of acute idiopathic neuropathy. II. Antecedent events.

Authors:  J B Winer; R A Hughes; M J Anderson; D M Jones; H Kangro; R P Watkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

6.  Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977.

Authors:  L B Schonberger; D J Bregman; J Z Sullivan-Bolyai; R A Keenlyside; D W Ziegler; H F Retailliau; D L Eddins; J A Bryan
Journal:  Am J Epidemiol       Date:  1979-08       Impact factor: 4.897

7.  Guillain-Barré syndrome in Western Australia, 1980-1985.

Authors:  G J Hankey
Journal:  Med J Aust       Date:  1987-02-02       Impact factor: 7.738

  7 in total
  15 in total

Review 1.  Guillain-Barré syndrome.

Authors:  U Seneviratne
Journal:  Postgrad Med J       Date:  2000-12       Impact factor: 2.401

Review 2.  Guillain-Barré syndrome--a classical autoimmune disease triggered by infection or vaccination.

Authors:  Eitan Israeli; Nancy Agmon-Levin; Miri Blank; Joab Chapman; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

3.  A risk worth taking?

Authors:  I Ralph Edwards
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 4.  Of floors and ceilings--defining, assuring, and communicating vaccine safety.

Authors:  R F Breiman; J A Zanca
Journal:  Am J Public Health       Date:  1997-12       Impact factor: 9.308

5.  Adverse drug effects and their clinical management: a personal view.

Authors:  I Ralph Edwards
Journal:  Drug Saf       Date:  2014-06       Impact factor: 5.606

6.  Causality Assessment in Pharmacovigilance: Still a Challenge.

Authors:  I Ralph Edwards
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

7.  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Jennifer L Liang; Tejpratap Tiwari; Pedro Moro; Nancy E Messonnier; Arthur Reingold; Mark Sawyer; Thomas A Clark
Journal:  MMWR Recomm Rep       Date:  2018-04-27

8.  Guillain-Barré syndrome following snake bite: An unusual complication.

Authors:  Abhishek Srivastava; A B Taly; Anupam Gupta; Aumir Moin; T Murali
Journal:  Ann Indian Acad Neurol       Date:  2010-01       Impact factor: 1.383

Review 9.  Emerging Infection, Vaccination, and Guillain-Barré Syndrome: A Review.

Authors:  Haruki Koike; Atsuro Chiba; Masahisa Katsuno
Journal:  Neurol Ther       Date:  2021-06-12

Review 10.  Emerging infectious diseases, vaccines and Guillain-Barré syndrome.

Authors:  Haruki Koike; Masahisa Katsuno
Journal:  Clin Exp Neuroimmunol       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.